165 related articles for article (PubMed ID: 25896775)
1. Systemic treatment approaches for sporadic desmoid-type fibromatosis: scarce evidence and recommendations.
Kasper B
Oncol Res Treat; 2015; 38(5):244-8. PubMed ID: 25896775
[TBL] [Abstract][Full Text] [Related]
2. Management of sporadic desmoid-type fibromatosis: a European consensus approach based on patients' and professionals' expertise - a sarcoma patients EuroNet and European Organisation for Research and Treatment of Cancer/Soft Tissue and Bone Sarcoma Group initiative.
Kasper B; Baumgarten C; Bonvalot S; Haas R; Haller F; Hohenberger P; Moreau G; van der Graaf WT; Gronchi A;
Eur J Cancer; 2015 Jan; 51(2):127-36. PubMed ID: 25434922
[TBL] [Abstract][Full Text] [Related]
3. An update on the management of sporadic desmoid-type fibromatosis: a European Consensus Initiative between Sarcoma PAtients EuroNet (SPAEN) and European Organization for Research and Treatment of Cancer (EORTC)/Soft Tissue and Bone Sarcoma Group (STBSG).
Kasper B; Baumgarten C; Garcia J; Bonvalot S; Haas R; Haller F; Hohenberger P; Penel N; Messiou C; van der Graaf WT; Gronchi A;
Ann Oncol; 2017 Oct; 28(10):2399-2408. PubMed ID: 28961825
[TBL] [Abstract][Full Text] [Related]
4. The management of desmoid tumours: A joint global consensus-based guideline approach for adult and paediatric patients.
Desmoid Tumor Working Group
Eur J Cancer; 2020 Mar; 127():96-107. PubMed ID: 32004793
[TBL] [Abstract][Full Text] [Related]
5. Desmoid tumors: To treat or not to treat, That is the question.
Kasper B; Raut CP; Gronchi A
Cancer; 2020 Dec; 126(24):5213-5221. PubMed ID: 33022074
[TBL] [Abstract][Full Text] [Related]
6. Sporadic desmoid-type fibromatosis: a stepwise approach to a non-metastasising neoplasm--a position paper from the Italian and the French Sarcoma Group.
Gronchi A; Colombo C; Le Péchoux C; Dei Tos AP; Le Cesne A; Marrari A; Penel N; Grignani G; Blay JY; Casali PG; Stoeckle E; Gherlinzoni F; Meeus P; Mussi C; Gouin F; Duffaud F; Fiore M; Bonvalot S;
Ann Oncol; 2014 Mar; 25(3):578-583. PubMed ID: 24325833
[TBL] [Abstract][Full Text] [Related]
7. Molecular Pathogenesis of Sporadic Desmoid Tumours and Its Implications for Novel Therapies: A Systematised Narrative Review.
McLean TD; Duchi S; Di Bella C
Target Oncol; 2022 May; 17(3):223-252. PubMed ID: 35446005
[TBL] [Abstract][Full Text] [Related]
8. Correlation of CTNNB1 Mutation Status with Progression Arrest Rate in RECIST Progressive Desmoid-Type Fibromatosis Treated with Imatinib: Translational Research Results from a Phase 2 Study of the German Interdisciplinary Sarcoma Group (GISG-01).
Kasper B; Gruenwald V; Reichardt P; Bauer S; Hohenberger P; Haller F
Ann Surg Oncol; 2016 Jun; 23(6):1924-7. PubMed ID: 26861905
[TBL] [Abstract][Full Text] [Related]
9. Desmoid tumors: need for an individualized approach.
de Bree E; Keus R; Melissas J; Tsiftsis D; van Coevorden F
Expert Rev Anticancer Ther; 2009 Apr; 9(4):525-35. PubMed ID: 19374605
[TBL] [Abstract][Full Text] [Related]
10. Imatinib induces sustained progression arrest in RECIST progressive desmoid tumours: Final results of a phase II study of the German Interdisciplinary Sarcoma Group (GISG).
Kasper B; Gruenwald V; Reichardt P; Bauer S; Rauch G; Limprecht R; Sommer M; Dimitrakopoulou-Strauss A; Pilz L; Haller F; Hohenberger P
Eur J Cancer; 2017 May; 76():60-67. PubMed ID: 28282612
[TBL] [Abstract][Full Text] [Related]
11. Aggressive fibromatosis in children: a changing approach.
Meazza C; Alaggio R; Ferrari A
Minerva Pediatr; 2011 Aug; 63(4):305-18. PubMed ID: 21909066
[TBL] [Abstract][Full Text] [Related]
12. New treatments for desmoid tumors.
Kasper B
Curr Opin Oncol; 2023 Jul; 35(4):292-295. PubMed ID: 37222208
[TBL] [Abstract][Full Text] [Related]
13. Medical treatment of mammary desmoid-type fibromatosis: which benefit?
Scheer L; Lodi M; Molière S; Kurtz JE; Mathelin C
World J Surg Oncol; 2017 Apr; 15(1):86. PubMed ID: 28420393
[TBL] [Abstract][Full Text] [Related]
14. Desmoid-Type Fibromatosis: Who, When, and How to Treat.
Martínez Trufero J; Pajares Bernad I; Torres Ramón I; Hernando Cubero J; Pazo Cid R
Curr Treat Options Oncol; 2017 May; 18(5):29. PubMed ID: 28439797
[TBL] [Abstract][Full Text] [Related]
15. Targeted therapy of desmoid-type fibromatosis: mechanism, current situation, and future prospects.
Wang Z; Wu J; Tian X; Hao C
Front Med; 2019 Aug; 13(4):427-437. PubMed ID: 30798508
[TBL] [Abstract][Full Text] [Related]
16. Whole-Genome and Transcriptome Sequencing Identified NOTCH2 and HES1 as Potential Markers of Response to Imatinib in Desmoid Tumor (Aggressive Fibromatosis): A Phase II Trial Study.
Kwon J; Lee JH; Lee YH; Lee J; Ahn JH; Kim SH; Kim SH; Kim TI; Yun KH; Park YS; Kim JE; Lee KS; Choi JK; Kim HS
Cancer Res Treat; 2022 Oct; 54(4):1240-1255. PubMed ID: 35038826
[TBL] [Abstract][Full Text] [Related]
17. Assessment of Physician's Systemic Treatment Preferences for Patients with Advanced Desmoid-Type Fibromatosis: Experience-Based Medicine in the Absence of High-Level Evidence.
Schöffski P; Requilé A; van Cann T
Oncol Res Treat; 2018; 41(4):214-219. PubMed ID: 29562221
[TBL] [Abstract][Full Text] [Related]
18. Response of extraabdominal desmoid tumors to therapy with imatinib mesylate.
Mace J; Sybil Biermann J; Sondak V; McGinn C; Hayes C; Thomas D; Baker L
Cancer; 2002 Dec; 95(11):2373-9. PubMed ID: 12436445
[TBL] [Abstract][Full Text] [Related]
19. Case report: A rare case of desmoid-type fibromatosis originating in the small intestine.
Xie J; Lai S; Wang Y; Ye B; Huang Z; Xi K
Front Med (Lausanne); 2023; 10():1291945. PubMed ID: 38020181
[TBL] [Abstract][Full Text] [Related]
20. Detection of beta-catenin mutations in paraffin-embedded sporadic desmoid-type fibromatosis by mutation-specific restriction enzyme digestion (MSRED): an ancillary diagnostic tool.
Amary MF; Pauwels P; Meulemans E; Roemen GM; Islam L; Idowu B; Bousdras K; Diss TC; O'Donnell P; Flanagan AM
Am J Surg Pathol; 2007 Sep; 31(9):1299-309. PubMed ID: 17721184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]